Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > sales

<< Previous

Bullboard Posts

Next >>

Comment by whitenorth72on Dec 14, 2023 3:23pm

137 Views

Post# 35785285

RE:sales

When the first official deal is secured this will merit their business plan and the PEA takes hold.
FDA approval should follow when funds are secured because Barium is a Critical mineral in the states.
Canada has dropped the ball by not including this mineral (probably because it didn't fit in the maple leaf design) but will soon regret it if a buyout does become a reality.

<< Previous

Bullboard Posts

Next >>

Top 10 pharmaceutical AI stocks